Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Silber

Showing results (191-200 of 214) with videos related to

Pageof 22
Sort By:
Journal of the National Cancer Institute|May 4, 1988
Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemiaH M Golomb, M J Ratain, A Fefer, et al.
Cancer Research|August 15, 1989
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analoguesY H Hsiang, L F Liu, M E Wall, et al.
Molecular Carcinogenesis|September 1, 1996
Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brainM D Dabholkar, M S Berger, J A Vionnet, et al.
DNA Repair|May 12, 2004
The Werner syndrome protein confers resistance to the DNA lesions N3-methyladenine and O6-methylguanine: implications for WRN functionA Blank, Michael S Bobola, Barry Gold, et al.
Blood|November 15, 1994
Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogsR Silber, B Degar, D Costin, et al.
Seminars in Oncology|June 1, 1987
Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemiaH M Golomb, A Fefer, D W Golde, et al.
Leukemia|February 20, 2003
IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cellsM C Levesque, M A Misukonis, C W O'Loughlin, et al.
ACS Nano|September 24, 2014
Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumorsZachary R Stephen, Forrest M Kievit, Omid Veiseh, et al.
Biomaterials|August 12, 2014
Proliferation and enrichment of CD133(+) glioblastoma cancer stem cells on 3D chitosan-alginate scaffoldsForrest M Kievit, Stephen J Florczyk, Matthew C Leung, et al.
Cancer Treatment Reports|September 1, 1985
Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group studyD S Ettinger, D M Finkelstein, G R Harper, et al.
Pageof 22

Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Journal of the National Cancer Institute|May 4, 1988
Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemiaH M Golomb, M J Ratain, A Fefer, et al.
Cancer Research|August 15, 1989
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analoguesY H Hsiang, L F Liu, M E Wall, et al.
Molecular Carcinogenesis|September 1, 1996
Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brainM D Dabholkar, M S Berger, J A Vionnet, et al.
DNA Repair|May 12, 2004
The Werner syndrome protein confers resistance to the DNA lesions N3-methyladenine and O6-methylguanine: implications for WRN functionA Blank, Michael S Bobola, Barry Gold, et al.
Blood|November 15, 1994
Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogsR Silber, B Degar, D Costin, et al.
Seminars in Oncology|June 1, 1987
Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemiaH M Golomb, A Fefer, D W Golde, et al.
Leukemia|February 20, 2003
IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cellsM C Levesque, M A Misukonis, C W O'Loughlin, et al.
ACS Nano|September 24, 2014
Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumorsZachary R Stephen, Forrest M Kievit, Omid Veiseh, et al.
Biomaterials|August 12, 2014
Proliferation and enrichment of CD133(+) glioblastoma cancer stem cells on 3D chitosan-alginate scaffoldsForrest M Kievit, Stephen J Florczyk, Matthew C Leung, et al.
Cancer Treatment Reports|September 1, 1985
Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group studyD S Ettinger, D M Finkelstein, G R Harper, et al.
Pageof 22